CN103230488A - Traditional Chinese medicine composition for treating lumbar disc herniation, osteoproliferation and cervical spondylosis - Google Patents
Traditional Chinese medicine composition for treating lumbar disc herniation, osteoproliferation and cervical spondylosis Download PDFInfo
- Publication number
- CN103230488A CN103230488A CN2013101547849A CN201310154784A CN103230488A CN 103230488 A CN103230488 A CN 103230488A CN 2013101547849 A CN2013101547849 A CN 2013101547849A CN 201310154784 A CN201310154784 A CN 201310154784A CN 103230488 A CN103230488 A CN 103230488A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- rhizoma
- preparata
- chinese medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating lumbar disc herniation, osteoproliferation and cervical spondylosis, which comprises the following raw materials in parts by weight: 10-15 parts of semen sinapis albae, 8-12 parts of garter snake, 10-12 parts of rhizoma ligustici chuanxiong, 10-15 parts of spina gleditsiae, 8-12 parts of radix angelicae, 5-10 parts of red flower, 3-5 parts of earthworm, 2-4 parts of musk, 3-5 parts of radix rehmanniae preparata, 3-4 parts of garden balsam stem, 2-3 parts of herba asari, 2-3 parts of caulis spatholobi, 1-2 parts of turtle shell, 2-3 parts of rhizoma seu radix notopterygii, 1-3 parts of radix saposhnikoviae, 2-3 parts of fructus gardeniae, 1-2 parts of radix aconiti kusnezoffii, 1-2 parts of Chinese angelica, 1-1.5 parts of tortoiseshell, 1-2 parts of long-noded pit viper, 0.5-1.5 parts of radix paeoniae rubra, 1-2 parts of radix aconiti preparata, 1-2 parts of cassia twig preparata, 0.5-1.5 parts of platycodon grandiflorum, 1-2 parts of arisaema cum bile, 0.6-1.2 parts of rhizoma atractylodis macrocephalae, 0.4-0.6 part of pinellia ternata, 0.3-0.5 part of radix astragali preparata, 0.5-0.6 part of radix aconiti carmichaeli, 0.4-0.5 part of eucommia ulmoides, 0.2-0.4 part of pangolin and 0.2-0.3 part of agkistrodon. According to the traditional Chinese medicine composition disclosed by the invention, the traditional Chinese medicine formula can realize functions of dredging channels and activating collaterals, activating blood and resolving stasis, eliminating edema and softening bone spur to achieve an aim of self-recovery of intervertebral disc, and has a good curative effect on treating lumbar disc herniation, osteoproliferation and cervical spondylosis while preventing toxic and side effects.
Description
Technical field
The present invention relates generally to the field of Chinese medicines, relates in particular to a kind of Chinese medicine composition for the treatment of prolapse of lumbar intervertebral disc, hyperosteogeny, cervical spondylosis.
Background technology
Prolapse of lumbar intervertebral disc, hyperosteogeny, cervical spondylosis are common frdquently encountered disease diseases.Treatment prolapse of lumbar intervertebral disc, cervical spondylosis, hyperosteogeny the best way are still taked traditional Chinese medical science expectant treatment at present, the prolapse of lumbar intervertebral disc hyperosteogeny, even operate on and recurrence also can occur, because operative treatment can damage the physiological structure of human body, and it is very big to the damage of body, add older patient, the patient of osteoporosis has these patients such as hypertension, coronary heart disease, heart disease to be not suitable for operative treatment.Existing Chinese medicine preparation on the market, the medicament composing prescription proportioning has nothing in common with each other, and drug effect is different, but really has the difficulty of significant curative effect to enumerate several.
Summary of the invention
The object of the invention is exactly in order to remedy the defective of prior art, a kind of Chinese medicine composition for the treatment of prolapse of lumbar intervertebral disc, hyperosteogeny, cervical spondylosis to be provided.It is evident in efficacy, and has no side effect.
The present invention is achieved by the following technical solutions:
A kind of prolapse of lumbar intervertebral disc for the treatment of, hyperosteogeny, the Chinese medicine composition of cervical spondylosis, the weight proportion of its each raw material components is: Semen Sinapis Albae 10-15, Zaocys 8-12, Rhizoma Chuanxiong 10-12, Spina Gleditsiae 10-15, Radix Angelicae Dahuricae 8-12, Flos Carthami 5-10, Pheretima 3-5, Moschus 2-4, Radix Rehmanniae Preparata 3-5, Herba speranskiae tuberculatae 3-4, Herba Asari 2-3, Caulis Spatholobi 2-3, Carapax Trionycis 1-2, Rhizoma Et Radix Notopterygii 2-3, Radix Saposhnikoviae 1-3, Fructus Gardeniae 2-3, Radix Aconiti Kusnezoffii 1-2, Radix Angelicae Sinensis 1-2, Carapax et Plastrum Testudinis 1-1.5, Agkistrodon 1-2, red Radix Paeoniae Alba 0.5-1.5, Radix Aconiti Preparata 1-2, Ramulus Cinnamomi 1-2 processed, Radix Platycodonis 0.5-1.5, Arisaema Cum Bile 1-2, Rhizoma Atractylodis Macrocephalae 0.6-1.2, Rhizoma Pinelliae 0.4-0.6, Radix Astragali Mongolici (processed) 0.3-0.5, Radix Aconiti Lateralis Preparata 0.5-0.6, Cortex Eucommiae 0.4-0.5, Squama Manis 0.2-0.4, Agkistrodon 0.2-0.3.
Preferably, a kind of prolapse of lumbar intervertebral disc for the treatment of, hyperosteogeny, the Chinese medicine composition of cervical spondylosis, the weight proportion of its each raw material components is: Semen Sinapis Albae 13, Zaocys 12, Rhizoma Chuanxiong 11, Spina Gleditsiae 10, the Radix Angelicae Dahuricae 8, Flos Carthami 5, Pheretima 4, Moschus 3, Radix Rehmanniae Preparata 3, Herba speranskiae tuberculatae 3, Herba Asari 3, Caulis Spatholobi 2, Carapax Trionycis 2, Rhizoma Et Radix Notopterygii 2, Radix Saposhnikoviae 2, Fructus Gardeniae 2, Radix Aconiti Kusnezoffii 2, Radix Angelicae Sinensis 1.5, Carapax et Plastrum Testudinis 1.5, Agkistrodon 1.5, the red Radix Paeoniae Alba 1, Radix Aconiti Preparata 1, Ramulus Cinnamomi 1 processed, Radix Platycodonis 1, Arisaema Cum Bile 1, the Rhizoma Atractylodis Macrocephalae 1, the Rhizoma Pinelliae 0.5, Radix Astragali Mongolici (processed) 0.5, Radix Aconiti Lateralis Preparata 0.5, the Cortex Eucommiae 0.5, Squama Manis 0.3, Agkistrodon 0.2.
By formulation weight the pulverizing of said herbal medicine thing is mixed thoroughly, make the powder bag, add 3-5 times of water during use and spray, be overlying on the affected part outward and get final product.
Year November in June, 2011 to 2012 Drug therapy prolapse of lumbar intervertebral disc of the present invention, hyperosteogeny, cervical spondylosis patient's 184 examples, case observation effective percentage, cure rate statistics are as follows:
The sick kind | The example number | Cure | Effectively | Invalid |
Prolapse of lumbar intervertebral disc | 82 | 72 | 8 | 2 |
Hyperosteogeny | 58 | 45 | 10 | 3 |
Cervical spondylosis | 44 | 36 | 7 | 1 |
According to above table, cure rate 83.2%, effective percentage 96.7%
Advantage of the present invention is:
Chinese medicine formula of the present invention can play dredge the meridian passage, blood circulation promoting and blood stasis dispelling, elimination edema, softening bony spur, reach intervertebral disc also receives the purpose that resets voluntarily, have better curative effect, and have no side effect for treatment prolapse of lumbar intervertebral disc, hyperosteogeny, cervical spondylosis.Processing technology of the present invention is simple, and curative effect is fast and remarkable, taking convenience, and low price has good social benefit and market prospect.
The specific embodiment
Embodiment
A kind of Chinese medicine composition for the treatment of prolapse of lumbar intervertebral disc, hyperosteogeny, cervical spondylosis, the weight of its each raw material components (gram) proportioning is: Semen Sinapis Albae 13, Zaocys 12, Rhizoma Chuanxiong 11, Spina Gleditsiae 10, the Radix Angelicae Dahuricae 8, Flos Carthami 5, Pheretima 4, Moschus 3, Radix Rehmanniae Preparata 3, Herba speranskiae tuberculatae 3, Herba Asari 3, Caulis Spatholobi 2, Carapax Trionycis 2, Rhizoma Et Radix Notopterygii 2, Radix Saposhnikoviae 2, Fructus Gardeniae 2, Radix Aconiti Kusnezoffii 2, Radix Angelicae Sinensis 1.5, Carapax et Plastrum Testudinis 1.5, Agkistrodon 1.5, the red Radix Paeoniae Alba 1, Radix Aconiti Preparata 1, Ramulus Cinnamomi processed 1, Radix Platycodonis 1, Arisaema Cum Bile 1, the Rhizoma Atractylodis Macrocephalae 1, the Rhizoma Pinelliae 0.5, Radix Astragali Mongolici (processed) 0.5, Radix Aconiti Lateralis Preparata 0.5, the Cortex Eucommiae 0.5, Squama Manis 0.3, Agkistrodon 0.2.
By formulation weight the pulverizing of said herbal medicine thing is mixed thoroughly, make the powder bag, add 4 times of water during use and spray, be overlying on the affected part outward and get final product.
Model case:
Case 1: Lee, the man, 35 years old, the Bozhou City people, cause lumbar vertebral injury because of undue force in March, 2012, and flank pain is not in time sought medical advice because of busy not drawing attention, and massage has several times been done in the massage parlor of just finding time, and massage back lumbar part pain has alleviation slightly; Increase the weight of because of the state of an illness of catching cold morning on April 20th, 2012, and the left thigh numbness has the pinprick sense, and felt to increase the weight of afternoon on the same day and extended to shank, the numb imperception of shank, the difficulty of walking, very painful; Be diagnosed as intervertebral disk hernia, and be waist CT to city's examination in hospital morning next day (April 21).The doctor has done the medicine of having adjusted and opened dehydration, anti-inflammatory analgetic to me, allows me go home to have a rest, and takes medicine to observe and says; Though pain had alleviation after April 27, medicine was eaten up, shank is still numb, shank imperception, difficulty in walking.Arrive the further consultation of city hospital again, the doctor advises operative treatment, considers expense and prognosis situation, does not agree operation, then seeks expectant treatment.Introduce by friend, do traction, massage treatment to an orthopaedics clinic, the state of an illness does not still have improvement after the week; When being the lumbar spondylosis worries, it is relatively good to listen other to say that Bozhou China ancestral health preserving hall is controlled lumbar spondylosis, just have in arms have a try go to have seeked advice to Bozhou China ancestral health preserving hall at heart, medication the same day can be in the moment Transdermal absorption, enter lesions position, promote QI-blood circulation, fast search, catch concealed wind, heat, wet, cold, the evil five poisonous creatures: scorpion, viper, centipede, house lizard, toad, promoting blood circulation to remove blood stasis, the pain in affected part, swelling, stiffly obviously alleviate, act on skeleton comprehensively, passages through which vital energy circulates, blood, internal organs, nourishing the liver and kidney makes the unblocked blood flowing of damaged tissues, the soft tissue that potent reparation is impaired, improve the self-healing ability of skeleton, make the skeleton of distortion recover normal, reach the purpose of reparation; Whole body unobstructed vessel, medication were walked energetically after 20 days, and hydrops, edema are discharged smoothly, and skeletal function is obviously improved; 25 days after wind of medication, cold, the wet lumbago that causes, limbs joint pain, swelling, morning, symptom such as deadlock, numb limbs and tense tendons was improved comprehensively; After the medication three months, symptom all disappears, so far not recurrence.
Case 2: Cao, the woman, 43 years old, the little pavilion people of Bozhou City Qiaocheng District Wu Ma town Wu accompanied paroxysmal bitterly because of the persistence nape and increases the weight of half a year, once accepted multiple treatment and did not see positive effect and examine.Have a medical check-up and see that cervical region is stiff, cervical region lives that oxycinesia increases the weight of and activity is obviously limited, the spinous process position of neck 3-6 all have in various degree by tenderness.Use Drug therapy of the present invention after 3 days, the nape pain obviously alleviates; Treat after 12 days the stiff improvement of cervical region; Transference cure when treating 20 days, the no abnormality seen of having a medical check-up.Take the photograph the variation of cervical part of esophagus X-ray film contrast iconography again, the slight protruding distortion in back of cervical part of esophagus physiologic radian before the treatment, treatment back physiologic radian recovers normal.
Case 3: Wang, man, 42 years old, Yue Lou people from village, Yue Lou administrative village, Bozhou City Qiaocheng District Zhang Dian township, outside nest place pain how behind the appearance lumbosacral region of no obvious inducement and the left lower extremity before 2 years, idol has numbness, pain increases the weight of during stimulation such as fatigue and cough, stands up difficulty night.Once at how tame hospital admission, accepted acupuncture, massage, eat treatments such as Chinese and western drugs, effect is not ideal always.Be illustrated in by the people and come to China ancestral's nourishing bone hall in January, 2012 and go to a doctor, carefully diagnose through the expert, disease is mainly L5/S1, and for the high-tension type is given prominence to, use Drug therapy of the present invention after 3 courses for the treatment of, malaise symptoms disappears substantially, so far recurrence, and do not have any discomfort sensation, it is normal that daily life and work recover already.
Claims (2)
1. treat prolapse of lumbar intervertebral disc for one kind, hyperosteogeny, the Chinese medicine composition of cervical spondylosis, it is characterized in that the weight proportion of its each raw material components is: Semen Sinapis Albae 10-15, Zaocys 8-12, Rhizoma Chuanxiong 10-12, Spina Gleditsiae 10-15, Radix Angelicae Dahuricae 8-12, Flos Carthami 5-10, Pheretima 3-5, Moschus 2-4, Radix Rehmanniae Preparata 3-5, Herba speranskiae tuberculatae 3-4, Herba Asari 2-3, Caulis Spatholobi 2-3, Carapax Trionycis 1-2, Rhizoma Et Radix Notopterygii 2-3, Radix Saposhnikoviae 1-3, Fructus Gardeniae 2-3, Radix Aconiti Kusnezoffii 1-2, Radix Angelicae Sinensis 1-2, Carapax et Plastrum Testudinis 1-1.5, Agkistrodon 1-2, red Radix Paeoniae Alba 0.5-1.5, Radix Aconiti Preparata 1-2, Ramulus Cinnamomi 1-2 processed, Radix Platycodonis 0.5-1.5, Arisaema Cum Bile 1-2, Rhizoma Atractylodis Macrocephalae 0.6-1.2, Rhizoma Pinelliae 0.4-0.6, Radix Astragali Mongolici (processed) 0.3-0.5, Radix Aconiti Lateralis Preparata 0.5-0.6, Cortex Eucommiae 0.4-0.5, Squama Manis 0.2-0.4, Agkistrodon 0.2-0.3.
2. a kind of prolapse of lumbar intervertebral disc for the treatment of according to claim 1, hyperosteogeny, the Chinese medicine composition of cervical spondylosis, it is characterized in that, the weight proportion of its each raw material components is: Semen Sinapis Albae 13, Zaocys 12, Rhizoma Chuanxiong 11, Spina Gleditsiae 10, the Radix Angelicae Dahuricae 8, Flos Carthami 5, Pheretima 4, Moschus 3, Radix Rehmanniae Preparata 3, Herba speranskiae tuberculatae 3, Herba Asari 3, Caulis Spatholobi 2, Carapax Trionycis 2, Rhizoma Et Radix Notopterygii 2, Radix Saposhnikoviae 2, Fructus Gardeniae 2, Radix Aconiti Kusnezoffii 2, Radix Angelicae Sinensis 1.5, Carapax et Plastrum Testudinis 1.5, Agkistrodon 1.5, the red Radix Paeoniae Alba 1, Radix Aconiti Preparata 1, Ramulus Cinnamomi 1 processed, Radix Platycodonis 1, Arisaema Cum Bile 1, the Rhizoma Atractylodis Macrocephalae 1, the Rhizoma Pinelliae 0.5, Radix Astragali Mongolici (processed) 0.5, Radix Aconiti Lateralis Preparata 0.5, the Cortex Eucommiae 0.5, Squama Manis 0.3, Agkistrodon 0.2.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310154784.9A CN103230488B (en) | 2013-04-28 | 2013-04-28 | Traditional Chinese medicine composition for treating lumbar disc herniation, osteoproliferation and cervical spondylosis |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310154784.9A CN103230488B (en) | 2013-04-28 | 2013-04-28 | Traditional Chinese medicine composition for treating lumbar disc herniation, osteoproliferation and cervical spondylosis |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103230488A true CN103230488A (en) | 2013-08-07 |
CN103230488B CN103230488B (en) | 2015-01-28 |
Family
ID=48878603
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310154784.9A Expired - Fee Related CN103230488B (en) | 2013-04-28 | 2013-04-28 | Traditional Chinese medicine composition for treating lumbar disc herniation, osteoproliferation and cervical spondylosis |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103230488B (en) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103505632A (en) * | 2013-08-31 | 2014-01-15 | 宋景戈 | Traditional Chinese medicine for treating hyperosteogeny |
CN103720973A (en) * | 2014-01-02 | 2014-04-16 | 陈洪瑜 | Chinese herbal medicine for treating lumbar disc herniation and preparation method thereof |
CN104474293A (en) * | 2014-10-17 | 2015-04-01 | 朱留臣 | Traditional Chinese medicine ointment for treating hyperosteogeny and preparing method thereof |
CN105327328A (en) * | 2015-12-12 | 2016-02-17 | 林炜 | Formula for treating osteoproliferation |
CN105641650A (en) * | 2015-12-23 | 2016-06-08 | 夏京奎 | Traditional Chinese medicine for treating cervical spondylosis |
CN106310207A (en) * | 2016-11-07 | 2017-01-11 | 罗建生 | Traditional Chinese medicine compound for treating hyperostosis or lumbar disc herination |
CN111388545A (en) * | 2020-04-14 | 2020-07-10 | 何增义 | Traditional Chinese medicine composition for treating lumbar vertebra diseases and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1031186A (en) * | 1988-03-29 | 1989-02-22 | 吴大勇 | The prescription and the facture of specially good effect bony spur antiphlogistine |
CN1237427A (en) * | 1998-06-02 | 1999-12-08 | 张起来 | Adhesive plaster for curing prolapse of lumbar intervertebral disk |
CN102125672A (en) * | 2010-01-12 | 2011-07-20 | 姚玉健 | Traditional Chinese medicine for treating cervical and lumbar spinal diseases and preparation method thereof |
-
2013
- 2013-04-28 CN CN201310154784.9A patent/CN103230488B/en not_active Expired - Fee Related
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1031186A (en) * | 1988-03-29 | 1989-02-22 | 吴大勇 | The prescription and the facture of specially good effect bony spur antiphlogistine |
CN1237427A (en) * | 1998-06-02 | 1999-12-08 | 张起来 | Adhesive plaster for curing prolapse of lumbar intervertebral disk |
CN102125672A (en) * | 2010-01-12 | 2011-07-20 | 姚玉健 | Traditional Chinese medicine for treating cervical and lumbar spinal diseases and preparation method thereof |
Non-Patent Citations (4)
Title |
---|
付秋玲等: "张吉治疗腰椎间盘突出症经验", 《中国中医药信息杂志》, vol. 17, no. 9, 30 September 2010 (2010-09-30) * |
帅海荣等: "中药分期辨证治疗腰椎间盘突出症临床观察", 《中医药临床杂志》, vol. 24, no. 5, 31 May 2012 (2012-05-31), pages 407 - 408 * |
张新华等: "腰椎间盘突出症常用中药及组方规律", 《中国民间疗法》, vol. 20, no. 5, 31 May 2012 (2012-05-31), pages 2 * |
张立清: "中医中药治疗颈椎骨质增生", 《内蒙古中医药》, 30 October 2011 (2011-10-30), pages 30 - 31 * |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103505632A (en) * | 2013-08-31 | 2014-01-15 | 宋景戈 | Traditional Chinese medicine for treating hyperosteogeny |
CN103505632B (en) * | 2013-08-31 | 2015-08-19 | 宋景戈 | A kind of Chinese medicine for the treatment of hyperosteogeny |
CN103720973A (en) * | 2014-01-02 | 2014-04-16 | 陈洪瑜 | Chinese herbal medicine for treating lumbar disc herniation and preparation method thereof |
CN103720973B (en) * | 2014-01-02 | 2016-08-17 | 陈洪瑜 | A kind of Chinese herbal medicine treating prolapse of lumbar intervertebral disc and preparation method thereof |
CN104474293A (en) * | 2014-10-17 | 2015-04-01 | 朱留臣 | Traditional Chinese medicine ointment for treating hyperosteogeny and preparing method thereof |
CN105327328A (en) * | 2015-12-12 | 2016-02-17 | 林炜 | Formula for treating osteoproliferation |
CN105641650A (en) * | 2015-12-23 | 2016-06-08 | 夏京奎 | Traditional Chinese medicine for treating cervical spondylosis |
CN106310207A (en) * | 2016-11-07 | 2017-01-11 | 罗建生 | Traditional Chinese medicine compound for treating hyperostosis or lumbar disc herination |
CN111388545A (en) * | 2020-04-14 | 2020-07-10 | 何增义 | Traditional Chinese medicine composition for treating lumbar vertebra diseases and preparation method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN103230488B (en) | 2015-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103230488B (en) | Traditional Chinese medicine composition for treating lumbar disc herniation, osteoproliferation and cervical spondylosis | |
CN100563690C (en) | A kind of medicine for the treatment of rheumatism, rheumatoid, puerperal exposure to wind, hyperosteogeny and disease of proplapse of lumbar intervertebral disc | |
CN103751310B (en) | A kind of traditional Chinese medicine for external application and its preparation method treating fascitis | |
CN101926957B (en) | Medicinal composition for treating arthralgia syndrome and preparation method thereof | |
CN104398982A (en) | Traditional Chinese medicine composition for treating traumatic injury and joint pain and swelling | |
CN102293853B (en) | Chinese medicinal pills for treating Bi syndrome | |
CN101690768B (en) | Vein and artery relieving pills for impediment of sinew | |
CN104840599A (en) | Medicine for treating ankylosing spondylitis | |
CN100372551C (en) | Chinese medicine for treating hyperosteogeny | |
CN103566278B (en) | Cortex torricelliae tiliifoliae | |
CN103495126A (en) | Traditional Chinese medicine composition treating rheumatism | |
CN106177819A (en) | A kind of external medicine composition for cervical spondylosis, preparation method and applications | |
CN105902969A (en) | External-use drug for treating pain in waist and lower extremities, process and application | |
CN1977899A (en) | Medicine for treating rheumatoid arthritis | |
CN1772245A (en) | Snake medicinal wine for health care massage and its application | |
CN105194227A (en) | Traditional Chinese medicine pills for treating leucoderma and preparation method of traditional Chinese medicine pills | |
CN105853969A (en) | Traditional Chinese medicine composition for treating lumbar disc herniation and lumbar spinal stenosis and preparation method thereof | |
CN101129718B (en) | Traditional Chinese medicine preparation for treating leuoderma | |
CN104825617A (en) | Traditional Chinese medicine for treating rheumatism bone disease and traditional Chinese medicine bag | |
CN1322886C (en) | Plaster for treating pain and prpearation thereof | |
CN104248677A (en) | Traditional Chinese medicinal preparation for treating erythema multiforme | |
CN104740003A (en) | Traditional Chinese medicine for treating lumbar disc herniation | |
CN103751467A (en) | Traditional Chinese medicine composition for treating lumbar and back myofascitis and preparation method thereof | |
CN102988833A (en) | Traditional Chinese medicine composition for treating rheumatism | |
CN100536895C (en) | Formulaion in traditional chinese medical prescription for treating waist and neck hyperosteogeny |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150128 Termination date: 20160428 |